Cargando…
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
Abstract A live attenuated influenza vaccine (LAIV) is currently approved in the United States for the prevention of influenza in individuals 2–49 years of age. This article summarizes the available data describing the safety and efficacy of LAIV for the prevention of influenza in both children and...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710797/ https://www.ncbi.nlm.nih.gov/pubmed/19453395 http://dx.doi.org/10.1111/j.1750-2659.2008.00056.x |